69
Views
0
CrossRef citations to date
0
Altmetric
Larynx

Can pepsin immunohistochemical staining of laryngeal lesions accurately diagnose non-acid laryngeal reflux?

, , &
Pages 524-527 | Received 28 Sep 2022, Accepted 21 Oct 2022, Published online: 16 Jun 2023

References

  • Lechien JR, Saussez S, Schindler A, et al. Clinical outcomes of laryngopharyngeal reflux treatment: a systematic review and meta-analysis. Laryngoscope. 2019;129(5):1174–1187.
  • Lechien JR, Akst LM, Hamdan AL, et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg. 2019;160(5):762–782.
  • Wang JS, Li JR, Li XY, et al. Is the pepsin immunohistochemical staining of laryngeal lesions an available way for diagnosing laryngopharyngeal reflux. Acta Otolaryngol. 2020;140(8):702–705.
  • Li JR, Wang JS, Wu MK, et al. The role of nonacid reflux in laryngopharyngeal reflux diseases. Eur Arch Otorhinolaryngol. 2020;277(10):2813–2819.
  • Lechien JR, Chan WW, Akst LM, et al. Normative ambulatory reflux monitoring metrics for laryngopharyngeal reflux: a systematic review of 720 healthy individuals. Otolaryngol Head Neck Surg. 2022;166(5):802–819.
  • Hoppo T, Sanz AF, Nason KS, et al. How much pharyngeal exposure is "normal"? normative data for laryngopharyngeal reflux events using hypopharyngeal multichannel intraluminal impedance (HMII). J Gastrointest Surg. 2012;16(1):16–24.
  • Formánek M, Jančatová D, Komínek P, et al. Comparison of impedance and pepsin detection in the laryngeal mucosa to determine impedance values that indicate pathological laryngopharyngeal reflux. Clin Transl Gastroenterol. 2017;8(10):e123.
  • Lechien JR, Bobin F, Muls V, et al. The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance-pH monitoring in patients with acid, non-acid and mixed laryngopharyngeal reflux. Clin Otolaryngol. 2021;46(3):602–613.
  • Oelschlager BK, Quiroga E, Isch JA, et al. Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment. J Gastrointest Surg. 2006;10(1):54–62.
  • Li JR, Wang JS, Wu MK, et al. Classification of the non-acid laryngopharyngeal reflux. Chin Med J (Engl). 2020;134(8):984–985.
  • Kowalik K, Krzeski A. The role of pepsin in the laryngopharyngeal reflux. Otolaryngol Pol. 2017;71(6):7–13.
  • Johnston N, Dettmar PW, Bishwokarma B, et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117(6):1036–1039.
  • Johnston N, Wells CW, Blumin JH, et al. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116(12):934–938.
  • Johnston N, Wells CW, Samuels TL, et al. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol. 2009;118(9):677–685.
  • Bulmer DM, Ali MS, Brownlee IA, et al. Laryngeal mucosa: its susceptibility to damage by acid and pepsin. Laryngoscope. 2010;120(4):777–782.
  • Parsel SM, Iarocci AL, Gastañaduy M, et al. Reflux disease and laryngeal neoplasia in nonsmokers and nondrinkers. Otolaryngol Head Neck Surg. 2020;163(3):560–562.
  • Wang SM, Freedman ND, Katki HA, et al. Gastroesophageal reflux disease: a risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP diet and health study cohort. Cancer. 2021;127(11):1871–1879.
  • Yanes M, Santoni G, Maret-Ouda J, et al. Laryngeal and pharyngeal squamous cell carcinoma after antireflux surgery in the 5 nordic countries. Ann Surg. 2022;276(2):e79–e85.
  • Lechien JR, Saussez S, Nacci A, et al. Association between laryngopharyngeal reflux and benign vocal folds lesions: a systematic review. Laryngoscope. 2019;129(9):E329–E341.
  • Nerurkar NK, Shah R. Factors responsible for the development of carbon granuloma post transoral laser cordectomy. Lasers Med Sci. 2019;34(7):1383–1389.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.